abstract |
The present invention provides compounds that are potent antagonists of CCR1 and possess anti-inflammatory activity in vivo. Said compounds are generally oxadiazole amide derivatives and are useful in pharmaceutical compositions and methods for the treatment of CCR1-mediated diseases and as controls in assays to identify competitive CCR1 antagonists. |